“Since 2018 I’ve had great experience with Dr. Rial and staff. Started with bleeding retinas, now no problems for almost a year.”
Diabetic Macular Edema With Good Vision: Do You Need Treatment Right Away?
What Causes the Swelling and What Raises Your Risk
Diabetic macular edema does not arise on its own. It develops from a broader process of blood vessel damage driven by diabetes, and several factors influence how quickly it progresses.
The root cause is diabetic retinopathy, the damage that high blood sugar does to retinal blood vessels over time. Weakened vessel walls develop small bulges and begin leaking fluid and fatty deposits. When that leakage reaches the macula, it produces the swelling described on this page.
In more advanced stages, diabetic retinopathy can also cause bleeding into the gel inside the eye, producing dark floating spots or cobweb streaks, or form scar tissue that pulls the retina away from the back of the eye. Those are separate, less common problems with their own warning signs, which are listed later on this page.
The same numbers that drive diabetes complications overall drive this one. Reaching goals for blood sugar, blood pressure, and cholesterol is recommended to lower the risk of diabetic retinopathy or slow its progression.
Managing your diabetes helps prevent or delay vision loss. This work does not guarantee your swelling will clear, but it aims at the same target as your eye care, and it is the part you have the most control over.
How long you have had diabetes matters, as does how far your retinopathy has already advanced. In a review of eyes with center-involving swelling and good starting vision followed over roughly five years, eyes with more advanced retinopathy at the start tended to fare worse over time.
That finding is a reason to stay in care, not a prediction of what will happen to your eye specifically. Close monitoring with treatment ready the moment your vision dips is what changes the outlook.
Symptoms to Watch For and How to Check Yourself at Home
Early diabetic macular edema often produces no symptoms at all. Knowing what to look for, and how to check between visits, helps you act quickly if something changes.
When symptoms do appear, they show up in the center of vision, not the edges. Reading may slow down, small print may smudge, and faces across a table may lose detail. Many people say they need more light than they used to.
These changes are usually gradual and do not mean you have missed your chance to act. They are your signal to move your appointment up.
Two patterns often go unnoticed. The first is a change in one eye only, because the stronger eye quietly compensates for the weaker one. The second is distortion rather than blur, such as a doorframe that appears to kink or bend slightly. Wavy vision and objects that appear to be different sizes in each eye are recognized features of macular swelling.
A simple home check can close the gap between appointments. Once a week, cover one eye and look at something with straight lines, such as a window frame or a door edge. Note whether any line bends or any area looks washed out or blank. Then switch eyes and repeat.
Many practices provide an Amsler grid, a printed square of fine lines, specifically for this purpose. Write down what you see, even when everything looks normal. A written record makes a real change easy to identify. Home checks support your monitoring plan but do not replace imaging scans.
How Diabetic Macular Edema Is Diagnosed and Tracked
Diagnosis and ongoing monitoring rely on a combination of imaging and examination. Understanding what each test does helps you know what to expect at your visits.
Diagnosis begins with drops that widen the pupil so your Retina Specialist can see the retina clearly. A dilated exam allows direct inspection of the retina, assessment of how far your diabetic retinopathy has advanced, and identification of swelling. Plan for a few hours of blurry, light-sensitive vision afterward, and bring sunglasses or arrange a driver.
Optical coherence tomography, or OCT, is a quick, painless light-based scan that produces a detailed cross-section of your retina. Nothing touches your eye and the scan takes only a minute or two. It shows precisely where fluid is sitting and provides a central thickness measurement that your doctor tracks over time.
That thickness number is why monitoring goes beyond the chart alone. Rising thickness can prompt a shorter follow-up interval even before your chart reading changes.
In this test, a dye is injected into a vein in your arm and a camera photographs it moving through the retinal blood vessels, revealing which ones are leaking. It is one of the standard tests used to evaluate macular swelling. Not everyone needs it at every visit, and many people never require one at all.
There is no single fixed interval for this situation. Follow-up is more frequent than a routine yearly diabetic eye check, and your OCT thickness and chart reading together determine the spacing rather than the calendar alone. Ask your Retina Specialist for your specific follow-up interval in writing, and ask what changes would prompt you to call sooner.
Watch Closely or Treat Right Away: What the Research Shows
The question of whether to treat immediately or monitor carefully has been studied directly in a large clinical trial. The results help explain why watching closely is considered a legitimate medical choice rather than simply doing nothing.
A clinical trial enrolled more than 700 adults with diabetes at nearly 100 sites across the United States and Canada. Each participant had one eye with center-involved swelling and vision of 20/25 or better. Eyes were randomly assigned to one of three plans: immediate anti-VEGF injections, laser treatment, or careful observation with treatment started only if vision dropped.
The design is what makes the results meaningful. Every group was monitored closely, and treatment was available and used the moment vision declined in the observation and laser groups.
At two years, the share of eyes that lost at least five letters of vision was similar across all three groups. About sixteen of every hundred eyes in the injection group, seventeen of every hundred in the laser group, and nineteen of every hundred in the observation group lost that amount of vision. The differences were small enough that they could have occurred by chance, and they were not statistically significant.
Of the eyes assigned to observation, about a third went on to receive injections during the two-year follow-up period. That means roughly two of every three observed eyes completed two years without needing an injection. Neither number predicts what will happen with your eye. They describe the range of outcomes a group of people in a similar situation faced.
Ophthalmology practice guidelines support deferring treatment in eyes with good visual acuity and center-involved swelling, until acuity is affected at 20/30 or worse. Anti-VEGF injections are effective once vision has dropped to that level. In practice, the trigger is a measured decline in your chart vision, sometimes combined with worsening OCT thickness.
This approach is called deferring, not declining treatment. Treatment is held ready and started on a defined signal, not abandoned.
Your Treatment Options and What Each One Involves
If and when treatment begins, several well-established options are available. Your Retina Specialist will recommend an approach based on the pattern of your leakage, your retinopathy stage, and your overall health.
Anti-VEGF (anti-vascular endothelial growth factor) drugs block the chemical signal that causes retinal blood vessels to leak. They are delivered by injection into the gel of the eye after numbing drops are applied. The injection itself takes only seconds. Most people describe a sensation of pressure rather than sharp pain, and the schedule of return visits is typically what people find most demanding.
Anti-VEGF drugs used for this condition include bevacizumab (Avastin), ranibizumab (Lucentis), aflibercept (Eylea), and faricimab (Vabysmo), among others. Your Retina Specialist will discuss which drug fits your situation and what it will cost you out of pocket.
Steroid medications placed inside the eye, including dexamethasone, fluocinolone acetonide (Iluvien), and triamcinolone acetonide, are also used to treat diabetic macular edema. They are generally not the first choice because of the risk of raising eye pressure and accelerating cataract formation, but they are an important option in certain cases.
Focal or grid laser photocoagulation (using light energy to seal leaking blood vessel areas away from the center of the macula) remains one of the established treatments for this condition. In the major clinical trial described above, laser results at two years were similar to both injection and observation groups. Laser is typically performed in a single office session rather than a repeating schedule.
Systemic control is not a substitute for eye treatment, but it works alongside it. Reaching goals for blood sugar, blood pressure, and cholesterol is recommended to lower the risk of diabetic retinopathy or slow its progression. Ask your diabetes care team for your current A1c and blood pressure readings and what targets they are aiming for.
Risks, Burdens, and a Realistic Outlook
Both watching and treating carry real considerations. Understanding what each path involves helps you make a decision you feel confident about.
The honest risk of a monitoring plan is that vision could decline between visits, or that follow-up appointments are missed. A review of eyes with center-involved swelling and good starting vision that were followed without a structured monitoring plan found that many of them lost some vision over several years. Eyes with more advanced retinopathy at the start tended to do worse.
The clinical trial shows the other side of that picture. With close monitoring and treatment started on a defined trigger, two-year vision outcomes were similar whether eyes began with injections, laser, or observation. Keeping appointments is what makes the watching approach safe.
Injections carry small but real risks. Endophthalmitis, a serious infection inside the eye, is a rare but recognized complication of intravitreal injections. Other risks associated with anti-VEGF injections include retinal detachment, a sharp rise in eye pressure in the hour following injection, and arterial blood clot events.
Eye infections after injection are treated urgently, which is why clinics ask you to call the same day if your eye becomes painful, red, or suddenly more blurry after a procedure. For most people, the practical burden is repeat visits, travel, and out-of-pocket costs rather than medical complications.
Every number on this page describes what happened to a group of people. The clinical trial was designed to compare outcomes across hundreds of eyes, not to predict what one individual eye will do. Your eye may sit anywhere within that range of outcomes, and no page or doctor can tell you in advance exactly where.
What the data does support is this: if you stay on schedule, a vision change is likely to be caught while treatment still has strong evidence behind it. That is a reason to feel steady rather than rushed.
Warning Signs That Need Prompt Attention
Diabetic macular edema itself does not usually require emergency care. However, people with diabetes are at risk for other retinal problems that do. Knowing the difference between a symptom worth watching and one that needs same-day attention can protect your vision.
Call your Retina Specialist or go to an urgent eye care facility the same day if you experience any of the following.
- A sudden shower of new floaters or a burst of dark spots and cobweb streaks in your vision
- A curtain, shadow, or dark veil moving across part of your sight
- Sudden or rapidly worsening vision loss in one eye over hours to a day
- New, repeated flashes of light
- A painful, red, or suddenly blurry eye in the days following an eye injection
These symptoms can indicate bleeding into the gel of the eye or a retinal detachment, which is when the retina pulls away from the back of the eye. Timing matters significantly for a detachment. Eyes where the central retina remains attached and surgery is performed promptly tend to have better outcomes than those repaired later. Most calls about these symptoms turn out to be something milder, but making the call costs you an afternoon, not your vision.
Some changes are not emergencies but should not wait until your next scheduled visit. Call within a few days if reading has become noticeably harder, if straight lines look bent on your home check, or if one eye seems worse than it did recently.
These are exactly the changes a monitoring plan is designed to catch. A measured drop in vision is the point at which guidelines recommend starting anti-VEGF treatment for center-involved swelling. An early call moves you into treatment on schedule.
Frequently Asked Questions
These questions address situations and decisions that often come up after a diagnosis of diabetic macular edema with good vision.
Based on the best available clinical trial in this exact situation, center-involved swelling with vision of 20/25 or better did not cause measurably more vision loss over two years compared to eyes that were treated immediately. The swelling is a real finding that needs ongoing tracking, but it is not costing you vision letters today. Your Retina Specialist can tell you whether your specific pattern of swelling and retinopathy stage changes that picture.
A decline in vision is the planned treatment trigger, not a sign that the monitoring approach has failed. In the clinical trial, eyes assigned to observation that later received injections after their vision dropped had similar two-year outcomes to eyes injected from the start. The condition that makes this work is close follow-up, so a decline is caught in weeks rather than months. If you notice a change at home before your next appointment, call right away rather than waiting.
Swelling can settle without treatment in some eyes. In the clinical trial, roughly two of every three eyes assigned to observation went through two years without needing an injection. However, that does not mean the fluid fully cleared in all of them, and it is not something to count on for any individual eye. It is precisely why your Retina Specialist tracks your OCT thickness number at each visit rather than assuming improvement or worsening.
More frequently than a routine yearly diabetic eye exam. The interval is set by your chart vision and OCT measurements, not the calendar alone. Intervals are typically shortened when the retina thickens and can be stretched when the eye stays stable. Ask at each visit when you are due back and what specific change would prompt you to call before then. Having that answer in writing helps you act quickly when it matters.
No. Eye treatment and diabetes management run in parallel, and injections are not delayed while you work on your A1c. However, reaching goals for blood sugar, blood pressure, and lipids is recommended to slow the underlying retinopathy, which drives the swelling in the first place. Think of them as separate lines of treatment that support each other rather than one being a prerequisite for the other.
Most people describe pressure and a brief sting rather than sharp pain. Numbing drops or gel are applied first, and the injection itself takes only a few seconds. Some people notice grittiness or a small red patch on the white of the eye for a day or two afterward, both of which are common and expected. Pain that begins or worsens in the hours or days following an injection is not expected and should be reported to your Retina Specialist the same day.
See Our Team at Atlantic Retina Center
Our team of fellowship-trained, board-certified Retina Specialists has provided specialized retinal care across the Delmarva peninsula since 2004, treating only the retina, vitreous, and macula. If you have been diagnosed with diabetic macular edema, or if you have diabetes and have not had a recent retinal evaluation, we encourage you to schedule an appointment at Atlantic Retina Center. Catching and monitoring this condition early, with the right imaging and the right expertise, is the foundation of protecting your vision for the long term.